Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Peptide Chemistry
Oral Delivery of Peptides
Nazneen Dewji, President and CEO of Cenna Biosciences leads a discussion on the strategies to overcome the challenges ‘Oral Delivery of Peptides’.
Immuno-Oncology
The Future of CAR T for Solid Tumours: Antigen Discovery, Persistence, and Fitness
CAR T, the rockstar therapy of immuno-oncology, finds its next big challenge in translating research for use in solid tumours.
Antibody & Protein Engineering
Top 3 Biologics News Headlines
Hot off the press, we look at this week’s breaking news stories from the Biologics industry.
Manufacturing & Bioprocessing
Gene Therapy Manufacturing
June's Discussion Group welcomed a panel of industry experts to debate manufacturing and standardisation challenges for the commercialisation of cell and gene therapies.
Antibody & Protein Engineering
Delays for New COVID Drugs
Clinical studies testing treatments for severe COVID-19 face major delays due to eligibility issues.
Stem Cell Therapy
Potency Assays for Thalassemia and Sickle Cell Disease Gene Therapy Drug Products
In this Commentary article, we explore how reductions in testing complexity can improve access to hematopoietic stem cell therapies for patients with blood disorders. The provision of safe, effective therapies will help to ameliorate the worst impacts of these disorders for patients and afford them a better quality of life.
Gene Therapy Development
Refining Analytics for Gene Delivery Systems
Key opinion leaders from Roche and Purespring Therapeutics debate future strategies for advancing cell and gene therapeutics.
Immuno-Oncology
Developing Novel Theranostic Approaches for the Development of Oncolytic Viruses
Single-cell, real-time analysis of oncolytic viruses’ efficacy, and replication in living cancer cells.
